PTC Therapeutics Inc (PTCT)
40.72
+0.25
(+0.62%)
USD |
NASDAQ |
Nov 04, 13:00
PTC Therapeutics 1 Year Total Returns (Daily): 119.3% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 119.3% |
October 31, 2024 | 112.9% |
October 30, 2024 | 117.0% |
October 29, 2024 | 129.6% |
October 28, 2024 | 118.7% |
October 25, 2024 | 75.04% |
October 24, 2024 | 78.29% |
October 23, 2024 | 86.56% |
October 22, 2024 | 69.41% |
October 21, 2024 | 65.62% |
October 18, 2024 | 90.73% |
October 17, 2024 | 79.57% |
October 16, 2024 | 83.32% |
October 15, 2024 | 84.21% |
October 14, 2024 | 91.96% |
October 11, 2024 | 76.15% |
October 10, 2024 | 71.30% |
October 09, 2024 | 87.07% |
October 08, 2024 | 88.75% |
October 07, 2024 | 61.99% |
October 04, 2024 | 65.57% |
October 03, 2024 | 73.13% |
October 02, 2024 | 71.52% |
October 01, 2024 | 60.87% |
September 30, 2024 | 65.55% |
Date | Value |
---|---|
September 27, 2024 | 61.41% |
September 26, 2024 | 66.64% |
September 25, 2024 | 62.41% |
September 24, 2024 | 52.68% |
September 23, 2024 | 53.64% |
September 20, 2024 | 43.52% |
September 19, 2024 | 40.81% |
September 18, 2024 | 46.13% |
September 17, 2024 | 33.55% |
September 16, 2024 | 28.60% |
September 13, 2024 | -11.99% |
September 12, 2024 | -19.02% |
September 11, 2024 | -19.71% |
September 10, 2024 | -23.02% |
September 09, 2024 | -23.31% |
September 06, 2024 | -21.70% |
September 05, 2024 | -18.83% |
September 04, 2024 | -16.19% |
September 03, 2024 | -16.64% |
August 30, 2024 | -12.85% |
August 29, 2024 | -12.87% |
August 28, 2024 | -12.07% |
August 27, 2024 | -11.08% |
August 26, 2024 | -12.11% |
August 23, 2024 | -13.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.38%
Minimum
Oct 17 2023
129.6%
Maximum
Oct 29 2024
1.77%
Average
-2.61%
Median
1 Year Total Returns (Daily) Benchmarks
Pfizer Inc | -2.51% |
Vertex Pharmaceuticals Inc | 27.56% |
BridgeBio Pharma Inc | -4.39% |
Cassava Sciences Inc | 21.62% |
Crinetics Pharmaceuticals Inc | 91.84% |